{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:32:17Z","timestamp":1792668737623,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1038\/nrc1452","type":"journal-article","created":{"date-parts":[[2004,10,27]],"date-time":"2004-10-27T18:44:59Z","timestamp":1098902699000},"page":"757-768","source":"Crossref","is-referenced-by-count":1888,"title":["Epstein\u2013Barr virus: 40 years on"],"prefix":"10.1038","volume":"4","author":[{"given":"Lawrence S.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B.","family":"Rickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrc1452_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"15","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A., Barr, Y. M. & Achong, B. G. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 15, 702\u2013703 (1964). The discovery of EBV \u2014 the first description of a virus based on the use of the electron microscope.","journal-title":"Lancet"},{"key":"BFnrc1452_CR2","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/JVI.61.5.1416-1420.1987","volume":"61","author":"GR Nemerow","year":"1987","unstructured":"Nemerow, G. R., Mold, C., Schwend, V. K., Tollefson, V. & Cooper, N. R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein\u2013Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complment fragment C3d. J. Virol. 61, 1416\u20131420 (1987).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0602-594","volume":"8","author":"CM Borza","year":"2002","unstructured":"Borza, C. M. & Hutt-Fletcher, L. M. Alternate replication in B-cells and epithelial cells switches tropism of Epstein\u2013Barr virus. Nature Med. 8, 594\u2013599 (2002).","journal-title":"Nature Med."},{"key":"BFnrc1452_CR4","first-page":"2511","volume-title":"Fields Virology","author":"E Kieff","year":"2001","unstructured":"Kieff, E. & Rickinson, A. B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2511\u20132574 (Lippincott Williams and Wilkins, Philadelphia, 2001)."},{"key":"BFnrc1452_CR5","first-page":"2575","volume-title":"Fields Virology","author":"E Kieff","year":"2001","unstructured":"Kieff, E. & Rickinson, A. B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2575\u20132627 (Lippincott Williams and Wilkins, Philadelphia, 2001)."},{"key":"BFnrc1452_CR6","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","volume":"6","author":"M Rowe","year":"1987","unstructured":"Rowe, M. et al. Differences in B cell growth phenotype reflect novel patterns of Epstein\u2013Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6, 2743\u20132751 (1987). First description of distinct forms of EBV latency in Burkitt's lymphoma cells, as compared to EBV-transformed B-cell lines.","journal-title":"EMBO J."},{"key":"BFnrc1452_CR7","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JVI.64.5.2309-2318.1990","volume":"64","author":"F Wang","year":"1990","unstructured":"Wang, F. et al. Epstein\u2013Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64, 2309\u20132318 (1990).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/375685a0","volume":"375","author":"J Levitskaya","year":"1995","unstructured":"Levitskaya, J. et al. Inhibition of antigen processing by the internal repeat region of the Epstein\u2013Barr virus nuclear antigen-1. Nature 375, 685\u2013688 (1995). Demonstration that the Gly-Ala-repeat domain of EBNA1 protects the protein from proteasome-mediated degradation.","journal-title":"Nature"},{"key":"BFnrc1452_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20031219","volume":"199","author":"KS Voo","year":"2004","unstructured":"Voo, K. S. et al. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein\u2013Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J. Exp. Med. 199, 459\u2013470 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrc1452_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20040121","volume":"199","author":"SP Lee","year":"2004","unstructured":"Lee, S. P. et al. CD8 T cell recognition of endogenously expressed Epstein\u2013Barr virus nuclear antigen 1. J. Exp. Med. 199, 1409\u20131420 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrc1452_CR11","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1084\/jem.20040191","volume":"199","author":"J Tellam","year":"2004","unstructured":"Tellam, J. et al. Endogenous presentation of CD8+ T cell epitopes from Epstein\u2013Barr virus-encoded nuclear antigen 1. J. Exp. Med. 199, 1421\u20131431 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrc1452_CR12","doi-asserted-by":"publisher","first-page":"10989","DOI":"10.1073\/pnas.1832776100","volume":"100","author":"S Humme","year":"2003","unstructured":"Humme, S. et al. The EBV nuclear antigen1 (EBNA1) enhances B cell immortalisation several thousandfold. Proc. Natl Acad. Sci. USA 100, 10989\u201310994 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR13","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","volume":"15","author":"JB Wilson","year":"1996","unstructured":"Wilson, J. B., Bell, J. L. & Levine, A. J. Expression of Epstein\u2013Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 15, 3117\u20133126 (1996).","journal-title":"EMBO J."},{"key":"BFnrc1452_CR14","doi-asserted-by":"publisher","first-page":"14269","DOI":"10.1073\/pnas.2336099100","volume":"100","author":"G Kennedy","year":"2003","unstructured":"Kennedy, G., Komano, J. & Sugden, B. Epstein\u2013Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl Acad. Sci. USA 100, 14269\u201314274 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/340393a0","volume":"340","author":"W Hammerschmidt","year":"1989","unstructured":"Hammerschmidt, W. & Sugden, B. Genetic analysis of immortalizing functions of Epstein\u2013Barr virus in human B lymphocytes. Nature 340, 393\u2013397 (1989).","journal-title":"Nature"},{"key":"BFnrc1452_CR16","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.1073\/pnas.86.23.9558","volume":"86","author":"JI Cohen","year":"1989","unstructured":"Cohen, J. I., Wang, F., Mannick, J. & Kieff, E. Epstein\u2013Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl Acad. Sci. USA 86, 9558\u20139562 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR17","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1073\/pnas.91.16.7568","volume":"91","author":"SR Grossman","year":"1994","unstructured":"Grossman, S. R., Johannsen, E., Tong, R., Yalamanchili, R. & Kieff, E. The Epstein\u2013Barr virus nuclear antigen 2 transactivator is directed to response elements by the J\u03ba recombination signal binding protein. Proc. Natl Acad. Sci. USA 91, 7568\u20137572 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1126\/science.7725102","volume":"268","author":"JJ Hsieh","year":"1995","unstructured":"Hsieh, J. J. & Hayward, S. D. Masking of the CBF1\/RBPJ\u03ba transcriptional repression domain by Epstein\u2013Barr virus EBNA2. Science 268, 560\u2013563 (1995). This and the previous paper were the first to show that EBNA2 influences gene transcription by affecting the notch\/RBP\u2013J\u03ba pathway.","journal-title":"Science"},{"key":"BFnrc1452_CR19","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1128\/JVI.65.12.6826-6837.1991","volume":"65","author":"JB Mannick","year":"1991","unstructured":"Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A. & Kieff, E. The Epstein\u2013Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65, 6826\u20136837 (1991).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR20","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/j.1460-2075.1994.tb06634.x","volume":"13","author":"AJ Sinclair","year":"1994","unstructured":"Sinclair, A. J., Palmero, I., Peters, G. & Farrell, P. J. EBNA-2 and EBNA-LP cooperate to cause G0 and G1 transition during immortalization of resting human B lymphocytes by Epstein\u2013Barr virus. EMBO J. 13, 3321\u20133328 (1994).","journal-title":"EMBO J."},{"key":"BFnrc1452_CR21","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/JVI.70.5.3068-3074.1996","volume":"70","author":"E Robertson","year":"1996","unstructured":"Robertson, E., Lin, J. & Kieff, E. The amino-terminal domains of Epstein\u2013Barr virus nuclear proteins 3A, 3B and 3C interact with RBPJ\u03ba. J. Virol. 70, 3068\u20133074 (1996).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR22","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1128\/JVI.70.7.4228-4236.1996","volume":"70","author":"B Zhao","year":"1996","unstructured":"Zhao, B., Marshall, D. R. & Sample, C. E. A conserved domain of the Epstein\u2013Barr virus nuclear antigens 3A and 3C binds to a discrete domain of J\u03ba. J. Virol. 70, 4228\u20134236 (1996).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR23","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.67.4.2014-2025.1993","volume":"67","author":"B Tomkinson","year":"1993","unstructured":"Tomkinson, B., Robertson, E. & Kieff, E. Epstein\u2013Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67, 2014\u20132025 (1993).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR24","first-page":"2541","volume":"13","author":"GA Parker","year":"1996","unstructured":"Parker, G. A. et al. Epstein\u2013Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13, 2541\u20132549 (1996).","journal-title":"Oncogene"},{"key":"BFnrc1452_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/sj.onc.1203327","volume":"19","author":"GA Parker","year":"2000","unstructured":"Parker, G. A., Touitou, R. & Allday, M. J. Epstein\u2013Barr virus EBNA3C can disrupte multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis. Oncogene 19, 700\u2013709 (2000).","journal-title":"Oncogene"},{"key":"BFnrc1452_CR26","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1128\/JVI.73.7.5688-5697.1999","volume":"73","author":"SA Radkov","year":"1999","unstructured":"Radkov, S. A. et al. Epstein\u2013Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J. Virol. 73, 5688\u20135697 (1999).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","volume":"43","author":"D Wang","year":"1985","unstructured":"Wang, D., Liebowitz, D. & Kieff, E. An EBV membrane protein expressed in immortalised lymphocytes transforms established rodent cells. Cell 43, 831\u2013840 (1985). First study to show that LMP1 functions as a classic oncogene in a rodent cell-transformation assay.","journal-title":"Cell"},{"key":"BFnrc1452_CR28","doi-asserted-by":"publisher","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","volume":"90","author":"KM Kaye","year":"1993","unstructured":"Kaye, K. M., Izumi, K. M. & Kieff, E. Epstein\u2013Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA 90, 9150\u20139154 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","volume":"65","author":"S Henderson","year":"1991","unstructured":"Henderson, S. et al. Induction of bcl-2 expression by Epstein\u2013Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65, 1107\u20131115 (1991).","journal-title":"Cell"},{"key":"BFnrc1452_CR30","doi-asserted-by":"crossref","first-page":"24157","DOI":"10.1016\/S0021-9258(18)35741-7","volume":"267","author":"CD Laherty","year":"1992","unstructured":"Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F. & Dixit, V. M. The Epstein\u2013Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor \u03baB. J. Biol. Chem. 267, 24157\u201324160 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1452_CR31","doi-asserted-by":"publisher","first-page":"16085","DOI":"10.1074\/jbc.274.23.16085","volume":"274","author":"AG Eliopoulos","year":"1999","unstructured":"Eliopoulos, A. G., Gallagher, N. J., Blake, S. M., Dawson, C. W. & Young, L. S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein\u2013Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274, 16085\u201316096 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1452_CR32","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1038\/sj.onc.1201258","volume":"14","author":"AG Eliopoulos","year":"1997","unstructured":"Eliopoulos, A. G. et al. Epstein\u2013Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-\u03baB pathway involving TNF receptor-associated factors. Oncogene 14, 2899\u20132916 (1997).","journal-title":"Oncogene"},{"key":"BFnrc1452_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","volume":"80","author":"G Mosialos","year":"1995","unstructured":"Mosialos, G. et al. The Epstein\u2013Barr virus transforming protein LMP1 engages signalling proteins for the tumour necrosis factor receptor family. Cell 80, 389\u2013399 (1995). Important study showing that LMP1 functions as a constitutively activated member of the TNF receptor family by interacting with common accessory proteins.","journal-title":"Cell"},{"key":"BFnrc1452_CR34","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.1093\/emboj\/16.20.6131","volume":"16","author":"O Gires","year":"1997","unstructured":"Gires, O. et al. Latent membrane protein 1 of Epstein\u2013Barr virus mimics a constitutively active receptor molecule. EMBO J. 16, 6131\u20136140 (1997).","journal-title":"EMBO J."},{"key":"BFnrc1452_CR35","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","volume":"17","author":"E Kilger","year":"1998","unstructured":"Kilger, E., Kieser, A., Baumann, M. & Hammerschmidt, W. Epstein\u2013Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700\u20131709 (1998).","journal-title":"EMBO J."},{"key":"BFnrc1452_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1126\/science.286.5438.300","volume":"286","author":"J Uchida","year":"1999","unstructured":"Uchida, J. et al. Mimicry of CD40 signals by Epstein\u2013Barr virus LMP1 in B lymphocyte responses. Science 286, 300\u2013303 (1999). In vivo demonstration that LMP1 can partially substitute for absence of the CD40 receptor.","journal-title":"Science"},{"key":"BFnrc1452_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1006\/scbi.2001.0410","volume":"11","author":"AG Eliopoulos","year":"2001","unstructured":"Eliopoulos, A. G. & Young, L. S. LMP1 structure and signal transduction. Semin. Cancer Biol. 11, 435\u2013444 (2001).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc1452_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0065-230X(00)79006-3","volume":"79","author":"R Longnecker","year":"2000","unstructured":"Longnecker, R. Epstein\u2013Barr virus latency: LMP2, a regulator or means for Epstein\u2013Barr virus persistence? Adv. Cancer Res. 79, 175\u2013200 (2000).","journal-title":"Adv. Cancer Res."},{"key":"BFnrc1452_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell, R. G., Wilson, J. B., Anderson, S. J. & Longnecker, R. Epstein\u2013Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405\u2013411 (1998).","journal-title":"Immunity"},{"key":"BFnrc1452_CR40","doi-asserted-by":"publisher","first-page":"10681","DOI":"10.1128\/JVI.74.22.10681-10689.2000","volume":"74","author":"F Scholle","year":"2000","unstructured":"Scholle, F., Bendt, K. M. & Raab-Traub, N. Epstein\u2013Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74, 10681\u201310689 (2000).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR41","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1182\/blood-2003-04-1018","volume":"102","author":"T Portis","year":"2003","unstructured":"Portis, T., Dyck, P. & Longnecker, R. Epstein\u2013Barr virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood 102, 4166\u20134178 (2003).","journal-title":"Blood"},{"key":"BFnrc1452_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/JVI.77.1.105-114.2003","volume":"77","author":"T Portis","year":"2003","unstructured":"Portis, T. & Longnecker, R. Epstein\u2013Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J. Virol. 77, 105\u2013114 (2003).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/scbi.2001.0413","volume":"11","author":"K Takada","year":"2001","unstructured":"Takada, K. & Nanbo, A. The role of EBERs in oncogenesis. Semin. Cancer Biol. 11, 461\u2013467 (2001).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc1452_CR44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/emboj\/21.5.954","volume":"21","author":"A Nanbo","year":"2002","unstructured":"Nanbo, A., Inoue, K., Adachi-Takasawa, K. & Takada, K. Epstein\u2013Barr virus RNA confers resistance to interferon-\u03b1-induced apoptosis in Burkitt's lymphoma. EMBO J. 21, 954\u2013965 (2002).","journal-title":"EMBO J."},{"key":"BFnrc1452_CR45","doi-asserted-by":"publisher","first-page":"10223","DOI":"10.1128\/JVI.74.21.10223-10228.2000","volume":"74","author":"IK Ruf","year":"2000","unstructured":"Ruf, I. K., Rhyne, P. W., Yang, C., Cleveland, J. L. & Sample, J. T. Epstein\u2013Barr virus small RNAs potentiate tumourigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J. Virol. 74, 10223\u201310228 (2000).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR46","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1002\/j.1460-2075.1989.tb08404.x","volume":"8","author":"MM Hitt","year":"1989","unstructured":"Hitt, M. M. et al. EBV gene expression in an NPC-related tumour. EMBO J. 8, 2639\u20132651 (1989).","journal-title":"EMBO J."},{"key":"BFnrc1452_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.177.2.339","volume":"177","author":"EM Deacon","year":"1993","unstructured":"Deacon, E. M. et al. Epstein\u2013Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177, 339\u2013349 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnrc1452_CR48","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1182\/blood.V93.9.3026","volume":"93","author":"H Chen","year":"1999","unstructured":"Chen, H., Smith, P., Ambinder, R. F. & Hayward, S. D. Expression of Epstein\u2013Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood 93, 3026\u20133032 (1999).","journal-title":"Blood"},{"key":"BFnrc1452_CR49","doi-asserted-by":"publisher","first-page":"8058","DOI":"10.1073\/pnas.89.17.8058","volume":"89","author":"L Karran","year":"1992","unstructured":"Karran, L., Gao, Y., Smith, P. R. & Griffin, B. E. Expression of a family of complementary-strand transcripts in Epstein\u2013Barr virus-infected cells. Proc. Natl Acad. Sci. USA 89, 8058\u20138062 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR50","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1128\/JVI.74.7.3082-3092.2000","volume":"74","author":"PR Smith","year":"2000","unstructured":"Smith, P. R. et al. Structure and coding content of CST (BART) family RNAs of Epstein\u2013Barr virus. J. Virol. 74, 3082\u20133092 (2000).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR51","first-page":"5584","volume":"60","author":"G Decaussin","year":"2000","unstructured":"Decaussin, G., Sbih-Lammali, F., de Turenne-Tessier, M., Bouguermouh, A. & Ooka, T. Expression of BARF1 gene encoded by Epstein\u2013Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res. 60, 5584\u20135588 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc1452_CR52","first-page":"2745","volume":"60","author":"A zur Hausen","year":"2000","unstructured":"zur Hausen, A. et al. Unique transcription pattern of Epstein\u2013Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res. 60, 2745\u20132748 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc1452_CR53","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/sj.onc.1204217","volume":"20","author":"W Sheng","year":"2001","unstructured":"Sheng, W., Decaussin, G., Sumner, S. & Ooka, T. N-terminal domain of BARF1 gene encoded by Epstein\u2013Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene 20, 1176\u20131185 (2001).","journal-title":"Oncogene"},{"key":"BFnrc1452_CR54","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V85.3.744.bloodjournal853744","volume":"85","author":"I Anagnostopoulos","year":"1995","unstructured":"Anagnostopoulos, I., Hummel, M., Kreschel, C. & Stein, H. Morphology, immunophenotype and distribution of latently and\/or productively Epstein\u2013Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein\u2013Barr virus. Blood 85, 744\u2013750 (1995).","journal-title":"Blood"},{"key":"BFnrc1452_CR55","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1074-7613(00)00048-0","volume":"13","author":"J Kurth","year":"2000","unstructured":"Kurth, J. et al. Epstein\u2013Barr virus-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13, 485\u2013495 (2000).","journal-title":"Immunity"},{"key":"BFnrc1452_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","volume":"9","author":"GJ Babcock","year":"1998","unstructured":"Babcock, G. J., Decker, L. L., Volk, M. & Thorley-Lawson, D. A. EBV persistence in memory B cells in vivo. Immunity 9, 395\u2013404 (1998). Important series of papers from the same group suggesting that EBV exploits the physiology of normal B-cell differentiation to persist within the memory-B-cell pool of the immunocompetent host.","journal-title":"Immunity"},{"key":"BFnrc1452_CR57","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1128\/JVI.78.10.5194-5204.2004","volume":"78","author":"D Hochberg","year":"2004","unstructured":"Hochberg, D. et al. Acute infection with Epstein\u2013Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J. Virol. 78, 5194\u20135204 (2004).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","volume":"13","author":"GJ Babcock","year":"2000","unstructured":"Babcock, G. J., Hochberg, D. & Thorley-Lawson, D. A. The expression pattern of Epstein\u2013Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13, 497\u2013506 (2000).","journal-title":"Immunity"},{"key":"BFnrc1452_CR59","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S1074-7613(02)00318-7","volume":"16","author":"LL Laichalk","year":"2002","unstructured":"Laichalk, L. L., Hochberg, D., Babcock, G. J., Freeman, R. B. & Thorley-Lawson, D. A. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity 16, 745\u2013754 (2002).","journal-title":"Immunity"},{"key":"BFnrc1452_CR60","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1084\/jem.20011692","volume":"195","author":"AD Hislop","year":"2002","unstructured":"Hislop, A. D., Annels, N. E., Gudgeon, N. H., Leese, A. M. & Rickinson, A. B. Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein\u2013Barr virus infection. J. Exp. Med. 195, 893\u2013905 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnrc1452_CR61","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","volume":"321","author":"L Young","year":"1989","unstructured":"Young, L. et al. Expression of Epstein\u2013Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 321, 1080\u20131085 (1989). First demonstration of EBV latent protein expression in post-transplantation lymphomas.","journal-title":"N. Engl. J. Med."},{"key":"BFnrc1452_CR62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(03)12271-4","volume":"361","author":"JM Timms","year":"2003","unstructured":"Timms, J. M. et al. Target cells of Epstein\u2013Barr virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet 361, 217\u2013223 (2003).","journal-title":"Lancet"},{"key":"BFnrc1452_CR63","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1182\/blood-2003-05-1683","volume":"102","author":"D Capello","year":"2003","unstructured":"Capello, D. et al. Molecular histogenesis of post-transplantation lymphoproliferative disorders. Blood 102, 3775\u20133785 (2003).","journal-title":"Blood"},{"key":"BFnrc1452_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1040-8428(00)00046-9","volume":"34","author":"JL Hsu","year":"2000","unstructured":"Hsu, J. L. & Glaser, S. L. Epstein\u2013Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit. Rev. Oncol. Hematol. 34, 27\u201353 (2000).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFnrc1452_CR65","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","volume":"184","author":"H Kanzler","year":"1996","unstructured":"Kanzler, H., Kuppers, R., Hansmann, M. L. & Rajewsky, K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumour clone derived from (crippled) germinal center B cells. J. Exp. Med. 184, 1495\u20131505 (1996). One of the first studies to isolate the malignant cells of Hodgkin's lymphoma and definitively determine the origin of these cells by immunoglobulin-gene sequencing.","journal-title":"J. Exp. Med."},{"key":"BFnrc1452_CR66","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0065-230X(02)84009-X","volume":"84","author":"R Kuppers","year":"2002","unstructured":"Kuppers, R. Molecular biology of Hodgkin's lymphoma. Adv. Cancer Res. 84, 277\u2013312 (2002).","journal-title":"Adv. Cancer Res."},{"key":"BFnrc1452_CR67","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","volume":"101","author":"I Schwering","year":"2003","unstructured":"Schwering, I. et al. Loss of the B lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101, 1505\u20131512 (2003).","journal-title":"Blood"},{"key":"BFnrc1452_CR68","doi-asserted-by":"publisher","first-page":"10411","DOI":"10.1073\/pnas.93.19.10411","volume":"93","author":"A Polack","year":"1996","unstructured":"Polack, A. et al. c-myc activation renders proliferation of Epstein\u2013Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Proc. Natl Acad. Sci. USA 93, 10411\u201310416 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR69","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","volume":"192","author":"AL Kovalchuk","year":"2000","unstructured":"Kovalchuk, A. L. et al. Burkitt lymphoma in the mouse. J. Exp. Med. 192, 1183\u20131190 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrc1452_CR70","doi-asserted-by":"publisher","first-page":"8146","DOI":"10.1073\/pnas.1432990100","volume":"100","author":"Z Li","year":"2003","unstructured":"Li, Z. et al. A global transcriptional regulatory role for c-myc in Burkitt's lymphoma. Proc. Natl Acad. Sci. USA 100, 8146\u20138169 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","volume":"12","author":"MS Lindstrom","year":"2002","unstructured":"Lindstrom, M. S. & Wiman, K. G. Role of genetic and epigenetic changes in Burkitt lymphoma. Semin. Cancer Biol. 12, 381\u2013387 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc1452_CR72","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood.V85.8.2176.bloodjournal8582176","volume":"85","author":"CJ Chapman","year":"1995","unstructured":"Chapman, C. J., Mockridge, C. I., Rowe, M., Rickinson, A. B. & Stevenson, F. K. Analysis of V-H genes used by neoplastic B cells in endemic Burkitts lymphoma shows somatic hypermutation and intraclonal heterogeneity. Blood 85, 2176\u20132181 (1995).","journal-title":"Blood"},{"key":"BFnrc1452_CR73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF03401587","volume":"1","author":"U Klein","year":"1995","unstructured":"Klein, U., Klein, G., Ehlin-Henriksson, B., Rajewsky, K. & Kuppers, R. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V-region genes. Mol. Med. 1, 495\u2013505 (1995).","journal-title":"Mol. Med."},{"key":"BFnrc1452_CR74","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1128\/JVI.75.21.10488-10492.2001","volume":"75","author":"RS Harris","year":"2001","unstructured":"Harris, R. S., Croom-Carter, D., Rickinson, A. B. & Neuberger, M. S. Epstein\u2013Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells. J. Virol. 75, 10488\u201310492 (2001).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR75","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/nm758","volume":"8","author":"G Kelly","year":"2002","unstructured":"Kelly, G., Bell, A. & Rickinson, A. B. Epstein\u2013Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA1. Nature Med. 8, 1098\u20131104 (2002).","journal-title":"Nature Med."},{"key":"BFnrc1452_CR76","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ijc.1404","volume":"93","author":"A Pajic","year":"2001","unstructured":"Pajic, A. et al. Antagonistic effects of c-myc and Epstein\u2013Barr virus latent genes on the phenotype of human B cells. Int. J. Cancer 93, 810\u2013816 (2001).","journal-title":"Int. J. Cancer"},{"key":"BFnrc1452_CR77","doi-asserted-by":"publisher","first-page":"15233","DOI":"10.1073\/pnas.211556598","volume":"98","author":"MS Kang","year":"2001","unstructured":"Kang, M. S., Hung, S. C. & Kieff, E. Epstein\u2013Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth. Proc. Natl Acad. Sci. USA 98, 15233\u201315238 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR78","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1073\/pnas.0730710100","volume":"100","author":"C Kiss","year":"2003","unstructured":"Kiss, C. et al. T cell leukaemia I oncogene expression depends on the presence of Epstein\u2013Barr virus in the virus-carrying Burkitt lymphoma lines. Proc. Natl Acad. Sci. USA 100, 4813\u20134818 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR79","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrc797","volume":"2","author":"C Boshoff","year":"2002","unstructured":"Boshoff, C. & Weiss, R. AIDS-related malignancies. Nature Rev. Cancer 2, 373\u2013382 (2002).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1452_CR80","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<326::AID-PATH242>3.0.CO;2-N","volume":"187","author":"I Araujo","year":"1999","unstructured":"Araujo, I. et al. Frequent expansion of Epstein\u2013Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J. Pathol. 187, 326\u2013330 (1999).","journal-title":"J. Pathol."},{"key":"BFnrc1452_CR81","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJM198803243181203","volume":"318","author":"JF Jones","year":"1988","unstructured":"Jones, J. F. et al. T-cell lymphomas containing Epstein\u2013Barr viral DNA in patients with chronic Epstein\u2013Barr virus infections. N. Engl. J. Med. 318, 733\u2013741 (1988).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc1452_CR82","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","volume":"335","author":"Y Harabuchi","year":"1990","unstructured":"Harabuchi, Y. et al. Epstein\u2013Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335, 128\u2013130 (1990).","journal-title":"Lancet"},{"key":"BFnrc1452_CR83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1040-8428(02)00115-4","volume":"44","author":"H Kanegane","year":"2002","unstructured":"Kanegane, H., Nomura, K., Miyawaki, T. & Tosato, G. Biological aspects of Epstein\u2013Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies. Crit. Rev. Oncol. Haematol. 44, 239\u2013249 (2002).","journal-title":"Crit. Rev. Oncol. Haematol."},{"key":"BFnrc1452_CR84","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/333455a0","volume":"333","author":"H Kikuta","year":"1988","unstructured":"Kikuta, H. et al. Epstein\u2013Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawaski-like disease. Nature 333, 455\u2013457 (1988).","journal-title":"Nature"},{"key":"BFnrc1452_CR85","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood.V81.10.2688.2688","volume":"81","author":"P Kanavaros","year":"1993","unstructured":"Kanavaros, P. et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein\u2013Barr virus. Blood 81, 2688\u20132695 (1993).","journal-title":"Blood"},{"key":"BFnrc1452_CR86","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1044579X0200086X","volume":"12","author":"N Raab-Traub","year":"2002","unstructured":"Raab-Traub, N. Epstein\u2013Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12, 431\u2013441 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc1452_CR87","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1044579X02000858","volume":"12","author":"MC Yu","year":"2002","unstructured":"Yu, M. C. & Yuan, J. M. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 12, 421\u2013429 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc1452_CR88","first-page":"956","volume":"46","author":"MC Yu","year":"1986","unstructured":"Yu, M. C., Ho, J. H., Lai, S. H. & Henderson, B. E. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case\u2013control study in Hong Kong. Cancer Res. 46, 956\u2013961 (1986).","journal-title":"Cancer Res."},{"key":"BFnrc1452_CR89","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/0092-8674(86)90803-2","volume":"47","author":"N Raab-Traub","year":"1986","unstructured":"Raab-Traub, N. & Flynn, K. The structure of the termini of the Epstein\u2013Barr virus as a marker of clonal cellular proliferation. Cell 47, 883\u2013889 (1986).","journal-title":"Cell"},{"key":"BFnrc1452_CR90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0065-230X(08)60027-5","volume":"44","author":"Y Zeng","year":"1985","unstructured":"Zeng, Y. Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv. Cancer Res. 44, 121\u2013138 (1985).","journal-title":"Adv. Cancer Res."},{"key":"BFnrc1452_CR91","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1093\/jnci\/94.21.1614","volume":"94","author":"ATC Chan","year":"2002","unstructured":"Chan, A. T. C. et al. Plasma Epstein\u2013Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J. Natl Cancer Inst. 94, 1614\u20131619 (2002).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1452_CR92","first-page":"1355","volume":"146","author":"R Pathmanathan","year":"1995","unstructured":"Pathmanathan, R. et al. Undifferentiated, non-keratinising, and squamous cell carcinoma of the nasopharynx. Variants of Epstein\u2013Barr virus-infected neoplasia. Am. J. Pathol. 146, 1355\u20131367 (1995).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1452_CR93","first-page":"769","volume":"140","author":"D Shibata","year":"1992","unstructured":"Shibata, D. & Weiss, L. M. Epstein\u2013Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 140, 769\u2013774 (1992).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1452_CR94","first-page":"1250","volume":"143","author":"M Tokunaga","year":"1993","unstructured":"Tokunaga, M. et al. Epstein\u2013Barr virus in gastric carcinoma. Am. J. Pathol. 143, 1250\u20131254 (1993).","journal-title":"Am. J. Pathol."},{"key":"BFnrc1452_CR95","doi-asserted-by":"publisher","first-page":"9131","DOI":"10.1073\/pnas.91.19.9131","volume":"91","author":"S Imai","year":"1994","unstructured":"Imai, S. et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein\u2013Barr virus latent infection protein. Proc. Natl Acad. Sci. USA 91, 9131\u20139135 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR96","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0046-8177(00)80197-5","volume":"31","author":"BG Schneider","year":"2000","unstructured":"Schneider, B. G. et al. Loss of p16\/CDKN2A tumour suppressor protein in gastric adenocarcinoma is associated with Epstein\u2013Barr virus and antomic location in the body of the stomach. Hum. Pathol. 31, 45\u201350 (2000).","journal-title":"Hum. Pathol."},{"key":"BFnrc1452_CR97","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1158\/1078-0432.CCR-1122-3","volume":"10","author":"HS Lee","year":"2004","unstructured":"Lee, H. S., Chang, M. S., Yang, H. K., Lee, B. L. & Kim, W. H. Epstein\u2013Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein\u2013Barr virus-negative carcinoma. Clin. Cancer Res. 10, 1698\u20131705 (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc1452_CR98","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/jcp.2003.014068","volume":"57","author":"A zur Hausen","year":"2004","unstructured":"zur Hausen, A. et al. Epstein\u2013Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. J. Clin. Pathol. 57, 487\u2013491 (2004).","journal-title":"J. Clin. Pathol."},{"key":"BFnrc1452_CR99","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/jnci\/91.16.1376","volume":"91","author":"M Bonnet","year":"1999","unstructured":"Bonnet, M. et al. Detection of Epstein\u2013Barr virus in invasive breast cancers. J. Natl Cancer Inst. 91, 1376\u20131381 (1999).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1452_CR100","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1006\/viro.1999.9619","volume":"256","author":"Y Sugawara","year":"1999","unstructured":"Sugawara, Y. et al. Detection of Epstein\u2013Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterised by the absence of EBV-encoded small RNA expression. Virology 256, 196\u2013202 (1999).","journal-title":"Virology"},{"key":"BFnrc1452_CR101","first-page":"2338","volume":"63","author":"PG Murray","year":"2003","unstructured":"Murray, P. G. et al. Reactivity with a monoclonal antibody to Epstein\u2013Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res. 63, 2338\u20132343 (2003).","journal-title":"Cancer Res."},{"key":"BFnrc1452_CR102","first-page":"171","volume":"62","author":"J-H Li","year":"2002","unstructured":"Li, J. -H. et al. Tumour-targeted gene therapy for nasopharyngeal carcinoma. Cancer Res. 62, 171\u2013178 (2002).","journal-title":"Cancer Res."},{"key":"BFnrc1452_CR103","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.ymthe.2003.08.018","volume":"8","author":"J-H Li","year":"2003","unstructured":"Li, J. -H. et al. Efficacy of targeted FasL in nasopharyngeal carcinoma. Mol. Ther. 8, 964\u2013973 (2003).","journal-title":"Mol. Ther."},{"key":"BFnrc1452_CR104","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1038\/sj.onc.1206548","volume":"22","author":"BF Israel","year":"2003","unstructured":"Israel, B. F. & Kenney, S. C. Virally targeted therapies for EBV-associated malignancies. Oncogene 22, 5122\u20135130 (2003).","journal-title":"Oncogene"},{"key":"BFnrc1452_CR105","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","volume":"78","author":"W-H Feng","year":"2004","unstructured":"Feng, W. -H., Hong, G., Delecluse, H. J. & Kenney, S. C. Lytic induction therapy for Epstein\u2013Barr virus-positive B-cell lymphomas. J. Virol. 78, 1893\u20131902 (2004).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR106","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1006\/scbi.1999.0137","volume":"9","author":"RF Ambinder","year":"1999","unstructured":"Ambinder, R. F., Robertson, K. D. & Tao, Q. DNA methylation and the Epstein\u2013Barr virus. Semin. Cancer Biol. 9, 369\u2013375 (1999).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc1452_CR107","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1200\/JCO.2004.04.185","volume":"22","author":"ATC Chan","year":"2004","unstructured":"Chan, A. T. C. et al. Azacitidine induces demethylation of the Epstein\u2013Barr virus genome in tumours. J. Clin. Oncol. 22, 1373\u20131381 (2004).","journal-title":"J. Clin. Oncol."},{"key":"BFnrc1452_CR108","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1086\/515290","volume":"177","author":"J Chodosh","year":"1998","unstructured":"Chodosh, J. et al. Eradication of latent Epstein\u2013Barr virus by hydroxyurea alters the growth-transformed cell phenotype. J. Infect. Dis. 177, 1194\u20131201 (1998).","journal-title":"J. Infect. Dis."},{"key":"BFnrc1452_CR109","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S0140-6736(00)02879-8","volume":"356","author":"KS Slobod","year":"2000","unstructured":"Slobod, K. S. et al. Epstein\u2013Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system. Lancet 356, 1493\u20131494 (2000).","journal-title":"Lancet"},{"key":"BFnrc1452_CR110","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/sj.gt.3300706","volume":"5","author":"A Piche","year":"1998","unstructured":"Piche, A., Kasono, K., Johanning, F., Curiel, T. J. & Curiel, D. T. Phenotypic knockout of the latent membrane protein 1 of Epstein\u2013Barr virus by an intracellular single-chain antibody. Gene Ther. 5, 1171\u20131179 (1998).","journal-title":"Gene Ther."},{"key":"BFnrc1452_CR111","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V92.5.1721","volume":"92","author":"JL Kenney","year":"1998","unstructured":"Kenney, J. L., Guinness, M. E., Curiel, T. & Lacy, J. Antisense to the Epstein\u2013Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and Bcl-2 expression and promotes apoptosis in EBV-immortalised B cells. Blood 92, 1721\u20131727 (1998).","journal-title":"Blood"},{"key":"BFnrc1452_CR112","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1073\/pnas.100119497","volume":"97","author":"ED Cahir-McFarland","year":"2000","unstructured":"Cahir-McFarland, E. D., Davidson, D. M., Schauer, S. L., Duong, J. & Kieff, E. NF\u03baB inhibition causes spontaneous apoptosis in Epstein\u2013Barr virus-transformed lymphoblastoid cells. Proc. Natl Acad. Sci. USA 97, 6055\u20136060 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR113","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1073\/pnas.0306482101","volume":"101","author":"CJ Farrell","year":"2004","unstructured":"Farrell, C. J. et al. Inhibition of Epstein\u2013Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Proc. Natl Acad. Sci. USA 101, 4625\u20134630 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR114","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/JVI.71.3.1766-1775.1997","volume":"71","author":"AL Kirchmaier","year":"1997","unstructured":"Kirchmaier, A. L. & Sugden, B. Dominant-negative inhibitors of EBNA-1 of Epstein\u2013Barr virus. J. Virol. 71, 1766\u20131775 (1997).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR115","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","volume":"345","author":"CM Rooney","year":"1995","unstructured":"Rooney, C. M. et al. Use of gene-modified virus-specific T lymphocytes to control Epstein\u2013Barr virus-related lymphoproliferation. Lancet 345, 9\u201313 (1995). First study to use adoptive transfer of EBV-specific T cells for the treatment of lymphoproliferative disease.","journal-title":"Lancet"},{"key":"BFnrc1452_CR116","doi-asserted-by":"publisher","first-page":"10391","DOI":"10.1073\/pnas.96.18.10391","volume":"96","author":"R Khanna","year":"1999","unstructured":"Khanna, R. et al. Activation and adoptive transfer of Epstein\u2013Barr virus-specific cytotoxic T cells in solid organ transplant patients with post-transplant lymphoproliferative disease. Proc. Natl Acad. Sci. USA 96, 10391\u201310396 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1452_CR117","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","volume":"360","author":"T Haque","year":"2002","unstructured":"Haque, T. et al. Treatment of Epstein\u2013Barr virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet 360, 436\u2013442 (2002).","journal-title":"Lancet"},{"key":"BFnrc1452_CR118","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V91.8.2925.2925_2925_2934","volume":"91","author":"MA Roskrow","year":"1998","unstructured":"Roskrow, M. A. et al. Epstein\u2013Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 91, 2925\u20132934 (1998).","journal-title":"Blood"},{"key":"BFnrc1452_CR119","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/14653240310001262","volume":"5","author":"HJ Wagner","year":"2003","unstructured":"Wagner, H. J. et al. Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15. Cytotherapy 5, 231\u2013240 (2003).","journal-title":"Cytotherapy"},{"key":"BFnrc1452_CR120","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.4049\/jimmunol.169.3.1593","volume":"169","author":"C Paludan","year":"2002","unstructured":"Paludan, C. et al. Epstein\u2013Barr nuclear antigen 1-specific CD4+ Th1 cells kill Burkitt's lymphoma cells. J. Immunol. 169, 1593\u20131603 (2002).","journal-title":"J. Immunol."},{"key":"BFnrc1452_CR121","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1128\/JVI.78.2.768-778.2004","volume":"78","author":"GS Taylor","year":"2004","unstructured":"Taylor, G. S. et al. Dual stimulation of Epstein\u2013Barr virus (EBV)-specific CD4+\/\u2212 and CD8+\/\u2212 T cell responses by a chimeric antigen construct: Potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma. J. Virol. 78, 768\u2013778 (2004).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR122","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood.V86.4.1493.bloodjournal8641493","volume":"86","author":"T Frisan","year":"1995","unstructured":"Frisan, T. et al. Local suppression of Epstein\u2013Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86, 1493\u20131501 (1995).","journal-title":"Blood"},{"key":"BFnrc1452_CR123","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.cgt.7700664","volume":"11","author":"HJ Wagner","year":"2004","unstructured":"Wagner, H. J. et al. A strategy for treatment of Epstein\u2013Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumour environment using tumour antigen-specific T cells. Cancer Gene Ther. 11, 81\u201391 (2004).","journal-title":"Cancer Gene Ther."},{"key":"BFnrc1452_CR124","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/310207a0","volume":"310","author":"R Baer","year":"1984","unstructured":"Baer, R. et al. DNA sequence and expression of the B95-8 Epstein\u2013Barr virus genome. Nature 310, 207\u2013211 (1984). Sequencing of the prototype strain of EBV \u2014 at the time, this was the largest region of DNA ever sequenced and the first human virus to be fully sequenced.","journal-title":"Nature"},{"key":"BFnrc1452_CR125","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/eji.200323765","volume":"33","author":"A Brauninger","year":"2003","unstructured":"Brauninger, A. et al. Epstein\u2013Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Eur. J. Immunol. 33, 1593\u20131602 (2003).","journal-title":"Eur. J. Immunol."},{"key":"BFnrc1452_CR126","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.194.7.927","volume":"194","author":"A Brauninger","year":"2001","unstructured":"Brauninger, A. et al. Survival and clonal expansion of mutating 'forbidden' (immunoglobulin receptor-deficient) Epstein\u2013Barr virus-infected B cells in angioimmunoblastic T cell lymphoma. J. Exp. Med. 194, 927\u2013940 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnrc1452_CR127","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199509143331103","volume":"333","author":"R Pathmanathan","year":"1995","unstructured":"Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K. & Raab-Traub, N. Clonal proliferations of cells infected with Epstein\u2013Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333, 693\u2013698 (1995). First demonstration of clonal EBV infection in pre-malignant lesions of the nasopharynx.","journal-title":"N. Engl. J. Med."},{"key":"BFnrc1452_CR128","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1044579X02000883","volume":"12","author":"K-W Lo","year":"2002","unstructured":"Lo, K. -W. & Huang, D. P. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol. 12, 451\u2013462 (2002). Important review summarizing the genetic and epigenetic events that contribute to the pathogenesis of NPC and indicating that some of these occur before EBV infection.","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc1452_CR129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1006\/viro.1996.0005","volume":"215","author":"PG Knox","year":"1996","unstructured":"Knox, P. G., Li, Q. X., Rickinson, A. B. & Young, L. S. In vitro production of stable Epstein\u2013Barr virus-positive epithelial cell clones which resemble the virus: cell interaction observed in nasopharyngeal carcinoma. Virology 215, 40\u201350 (1996).","journal-title":"Virology"},{"key":"BFnrc1452_CR130","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1128\/JVI.74.4.1939-1947.2000","volume":"74","author":"S Zhou","year":"2000","unstructured":"Zhou, S., Fujimuro, M., Hsieh, J. J., Chen, L. & Hayward, S. D. A role for SKIP in EBNA2 activation of CBF1-repressed promoters. J. Virol. 74, 1939\u20131947 (2000).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR131","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1126\/science.7716513","volume":"268","author":"S Artavanis-Tsakonas","year":"1995","unstructured":"Artavanis-Tsakonas, S., Matsuno, K. & Fortini, M. E. Notch signaling. Science 268, 225\u2013232 (1995).","journal-title":"Science"},{"key":"BFnrc1452_CR132","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1128\/JVI.72.7.6034-6039.1998","volume":"72","author":"T Sakai","year":"1998","unstructured":"Sakai, T. et al. Functional replacement of the intracellular region of the Notch1 receptor by Epstein\u2013Barr virus nuclear antigen 2. J. Virol. 72, 6034\u20136039 (1998).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR133","first-page":"549","volume":"10","author":"DS Huen","year":"1995","unstructured":"Huen, D. S., Henderson, S. A., Croom-Carter, D. & Rowe, M. The Epstein\u2013Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-\u03baB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10, 549\u2013560 (1995).","journal-title":"Oncogene"},{"key":"BFnrc1452_CR134","doi-asserted-by":"publisher","first-page":"7557","DOI":"10.1038\/sj.onc.1207120","volume":"22","author":"AG Eliopoulos","year":"2003","unstructured":"Eliopoulos, A. G. et al. Epstein\u2013Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF\u03baB2 to p52 via an IKK\u03b3\/NEMO-independent signalling pathway. Oncogene 22, 7557\u20137569 (2003).","journal-title":"Oncogene"},{"key":"BFnrc1452_CR135","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1074-7613(01)00089-9","volume":"14","author":"ML Dykstra","year":"2001","unstructured":"Dykstra, M. L., Longnecker, R. & Pierce, S. K. Epstein\u2013Barr virus coopts lipid rafts to block the signalling and antigen transport functions of the BCR. Immunity 14, 57\u201367 (2001).","journal-title":"Immunity"},{"key":"BFnrc1452_CR136","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1006\/viro.1999.0166","volume":"268","author":"M Ikeda","year":"2000","unstructured":"Ikeda, M., Ikeda, A., Longan, L. C. & Longnecker, R. The Epstein\u2013Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology 268, 178\u2013191 (2000).","journal-title":"Virology"},{"key":"BFnrc1452_CR137","doi-asserted-by":"publisher","first-page":"9556","DOI":"10.1128\/JVI.76.18.9556-9561.2002","volume":"76","author":"S-Y Chen","year":"2002","unstructured":"Chen, S. -Y., Lu, J., Shih, Y. -C. & Tsai, C. -H. Epstein\u2013Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J. Virol. 76, 9556\u20139561 (2002).","journal-title":"J. Virol."},{"key":"BFnrc1452_CR138","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","volume":"22","author":"LS Young","year":"2003","unstructured":"Young, L. S. & Murray, P. G. Epstein\u2013Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22, 5108\u20135121 (2003).","journal-title":"Oncogene"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc1452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1452","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:28:53Z","timestamp":1684441733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc1452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":138,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["BFnrc1452"],"URL":"https:\/\/doi.org\/10.1038\/nrc1452","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}